Home > Products > CD2 & CD4 > Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (IgG-Fv)

Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (IgG-Fv)  (BSGV-193)

Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD2 antibody variable domain is fused to the C terminal of an IgG of anti-CD4 antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can block two antigens simultaneously. It is designed for the research of HIV-1 infection, AIDS therapy.

Specifications

Targets
CD2 & CD4
Type
IgG-Fv
Species Reactivity
Human
Target 1
CD2
Host Animal 1
Mouse
Target 2
CD4
Host Animal 2
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
HIV-1 infection, AIDS

Targets

Target 1
CD2
Gene ID
UniProt ID
Alternative Names
CD2; CD2 molecule; T11; SRBC; LFA-2; T-cell surface antigen CD2; leukocyte function-associated antigen-2; LFA-3 receptor; rosette receptor; erythrocyte receptor; lymphocyte-function antigen-2; T-cell surface antigen T11/Leu-5; CD2 antigen (p50), sheep red blood cell receptor
Target 2
CD4
Gene ID
UniProt ID
Alternative Names
CD4; CD4 molecule; CD4mut; T-cell surface glycoprotein CD4; CD4 receptor; CD4 antigen (p55); T-cell surface antigen T4/Leu-3

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (IgG-Fv) (BSGV-193). Click the button below to contact us or submit your feedback about this product.

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY
Related products of "CD2 & CD4"
See other bsAb targets related to "CD2"

See other bsAb targets related to "CD4"

Online Inquiry

24x7 Service quality
USA

Tel:
Fax:
Email:

UK

Tel:
Email:

Germany

Tel:
Email: